⌘K

Login Start Free

Home/Filings/4/0001179022-16-000134

4//SEC Filing

GALECTIN THERAPEUTICS INC 4

Accession 0001179022-16-000134

$GALTCIK 0001133416operating

View on SEC.gov Company Profile

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 4:27 PM ET

Size

5.3 KB

Accession

0001179022-16-000134

Insider Transaction Report

Form 4

Period: 2016-12-15

GALECTIN THERAPEUTICS INCGALT

Director

Transactions

Award
Stock option (right to buy)
2016-12-15+31,250→ 31,250 total
Exercise: $0.89Exp: 2026-12-15→ Common stock (31,250 underlying)

Footnotes (1)

[F1]The options vest 100% on the date of Galectin Therapeutics, Inc.'s 2017 Annual Stockholders Meeting.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

GALECTIN THERAPEUTICS INC

CIK 0001133416

Entity typeoperating

IncorporatedNV

Related Parties

1

filerCIK 0001133416

Filing Metadata

Form type: 4
Filed: Dec 18, 7:00 PM ET
Accepted: Dec 19, 4:27 PM ET
Size: 5.3 KB

View on SEC.gov